OS Therapies CEO on its latest clinical advancements
CEO & Founder Conversations
•
4m 43s
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
Up Next in CEO & Founder Conversations
-
CoachHub CEO on making coaching more ...
Matti Niebelschütz, CEO & Co-Founder of CoachHub, discusses the future of coaching in the ‘people era,’ how AI is making coaching more accessible, and the role of AIMY™ AI Coach in transforming workplace learning on #NYSEFloorTalk with Judy Shaw.
-
OS Therapies CEO on clinical advancem...
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
-
Titan America CEO on driving innovati...
Bill Zarkalis, CEO and President of Titan America, a leading heavy building materials producer in the U.S., joined Judy Shaw on #NYSEFloorTalk to discuss how the company is driving innovation and sustainability in the industry.
